Case study

Eli Lilly

Increased operational flexibility within packaging requirements

We were commissioned to compare and assess capabilities, approach and methodologies across manufacturing sites in Europe and North America. This helped Eli Lilly in identifying and capitalizing on operational best practice across the sites and benchmarked these opportunities against pharmaceutical and other manufacturing businesses.

Business Challenge

Many pharmaceutical manufacturers had invested through the 1980’s and 90’s in high speed, high efficiency lines, built for long, sustained runs. However, the global marketplace is increasing demanding more flexibility, shorter runs, low costs. Ethical Pharma producers are also seeing margins eroded by low cost generics competitors and regulators are driving more diversity into the market; adding further complexity, driving down run lengths, increasing inventories and costs.